Clinical Trial Update: Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on gut microbiota reconstruction for irritable bowel syndrome with predominant diarrhea, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: UNKNOWN